propafenone has been researched along with Genetic Predisposition in 2 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bjerregaard, P | 1 |
Gussak, I | 1 |
Lehtonen, A | 1 |
Fodstad, H | 1 |
Laitinen-Forsblom, P | 1 |
Toivonen, L | 1 |
Kontula, K | 1 |
Swan, H | 1 |
1 review available for propafenone and Genetic Predisposition
Article | Year |
---|---|
Short QT syndrome: mechanisms, diagnosis and treatment.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Death, Sudden, Cardiac; Electric Countershock; Electroc | 2005 |
1 other study available for propafenone and Genetic Predisposition
Article | Year |
---|---|
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; DNA Mutational Analysis; Electrocardiog | 2007 |